AzTrials
AzTrials

Executive FunctionNANCYNCT05593965

Causal Role of Frontostriatal Circuitry in Goal-directed Behavior

A study testing Delta-beta TMS, Theta-gamma TMS and Arrhythmic TMS in people with Executive Function, run by University of North Carolina, Chapel Hill at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this clinical trial is to investigate the causal role that frontostriatal circuitry plays in goal-directed behavior. The participants will perform a reward-based decision-making task. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Executive Function
What is being tested?
Delta-beta TMS, Theta-gamma TMS and Arrhythmic TMS
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
10 Jan 2023to 31 Jul 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy
  • Between the ages of 18 and 35
  • Right handed
  • Able to provide informed consent
  • Willing to comply with all study procedures
  • Available for the duration of the study
  • Speak and understand English.

Who cannot join

  • Attention Deficit Hyperactivity Disorder (currently under treatment)
  • Neurological disorders and conditions, including, but not limited to: History of epilepsy Seizures (except childhood febrile seizures)
  • Dementia
  • History of stroke
  • Parkinson's disease
  • Multiple sclerosis
Show all 16Show fewer
  • Cerebral aneurysm
  • Brain tumors
  • Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, human immunodeficiency virus or acquired immunodeficiency syndrome, malignancy, liver or renal impairment)
  • Prior brain surgery
  • Any brain devices/implants, including cochlear implants and aneurysm clips
  • Cardiac pacemaker
  • Any other implanted electronic device
  • History of current traumatic brain injury
  • (For females) Pregnancy or breast feeding
  • Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599

Other trials in United States

About this study

The purpose of this clinical trial is to investigate the causal role that frontostriatal circuitry plays in goal-directed behavior. The participants will perform a reward-based decision-making task. During the task, cross-frequency patterned rhythmic transcranial magnetic stimulation (TMS) will be delivered at delta-beta frequency, a control-frequency, or an active sham to either the dorsolateral or medial prefrontal cortex (PFC). Electroencephalography will be collected concurrent with stimulation. Structural and functional magnetic resonance imaging (MRI) will be collected during performance of the reward-based decision-making task to localize the stimulation targets.

Read the detailed description

This study is a pilot, four-session, crossover study with transcranial magnetic stimulation (TMS), electroencephalography (EEG), and magnetic resonance imaging (MRI) to understand the causal role of delta-beta coupling in goal-directed behavior in the dorsolateral prefrontal cortex (dlPFC) to dorsal striatum circuit. Participants that request to be in the experiment will provide verbal, documented consent to undergo a phone screening to assess that the participant meets initial exclusion/inclusion criteria. Participants complete an MRI and TMS screening form over the phone to ensure eligibility.

The first session will be an EEG session with the reward-based decision-making task. At the start of the session, the investigators will acquire written informed consent. Then, the investigators will administer a pregnancy test if applicable. Participants will complete five assessments: the Snaith Hamilton Pleasure Scale, Behavioral Activation System and Behavioral Inhibition System, Temporal Experience of Pleasure Scale, the State-Trait Anxiety Inventory, and Ruminative Responses Scale. Note that the participants are from a convenient sample and are not required to be diagnosed with major depressive disorder. Thus, these assessments were selected as they survey various personality traits that might be relevant to performance in the task.

The scalp dimensions of each participant are calculated and an EEG net is applied. Next, the participants complete an eyes-open and eyes-closed resting-state recording of EEG. Then, the streamlined version of the Expenditure of Effort for Reward Task (S-EEfRT) is completed. These data serve as baseline measurement of brain activity without any form of stimulation. This session takes approximately 1.5 hours to complete. After each block of the task, the task difficulty will increase or decrease based on performance. At the end of the session, if the participant chose to perform the hard task greater than 85% of the time or less than 15% of the time, then the participant will not be invited to the next session of the experiment. Participants that do not dynamically change their response based on the incentive are not engaged with the relevant cognitive constructs under investigation in this study.

The second session takes place at the MRI facility. In the 24 hours prior to this session, participants complete an MRI screening form to ensure eligibility based on common contraindications for MRI. During the 60 minutes of scanning, a 5-minute structural MR is acquired and the remaining time is used to complete as many blocks of the S-EEfRT as possible. The minimal number of sessions required to use the data is 5 blocks, which requires approximately 25 minutes to collect. If a participant was unable to complete the requisite number of sessions, then they will be excluded from the study. Functional MRI data is analyzed before the 3rd and 4th session to localize the regions of dorsolateral prefrontal cortex (dlPFC) and medial prefrontal cortex (mPFC) for stimulation. In the localization analysis, a region of interest mask in the head of the left caudate and in left nucleus accumbens are drawn and the region in dlPFC and mPFC with peak functional connectivity in task-based functional connectivity to these regions. In a pilot dataset collected by the investigators, it was found that the contrast of trails in which there was a decision to perform the hard task versus trials in which the easy task was selected was sufficient to localize the anterior middle frontal gyrus. The contrast of trials in which high versus low incentive was offered was sufficient to localize the medial prefrontal cortex. Thus, the investigators will choose regions in these anatomical areas with maximal connectivity to their respective nucleus in the striatum.

The order of regions (dlPFC then mPFC, or mPFC then dlPFC) targeted by TMS in the third and fourth session will be randomized and counter-balanced. In the third and fourth session, participants will complete a TMS contraindications screening form. The same TMS screening form will be administered over the phone and at the start of each of the TMS session. If there is any ambiguity in the contraindications for the TMS form, then the medical monitor who is an epileptologist is consulted and final approval is acquired. Participants will be fitted with a low-profile EEG net. In the third session, the motor threshold of each participant will be calculated using single-pulse TMS to the hand knob of the left primary motor cortex with real-time monitoring of the motor-evoked potential using electrodes on the first dorsal interosseus muscle. Researchers may also use visible twitch to calculate the motor threshold. The motor threshold is defined as the percent stimulator output when a motor-evoked potential or visible twitch is observed approximately 50% of the time. For the fourth session, the same stimulator intensity will be used as in the third session. The structural MRI and regions of interest (dlPFC and mPFC) are imported into neuronavigation software. The participant wears a three-dimensional stereotaxic tracking headband and their head is registered to their structural MRI using canonical coordinates on the scalp. Then, the TMS coil is targeted to either mPFC or dlPFC and the position of the coil relative to the head is recorded throughout the session. The participant performs the S-EEfRT as the patterned trains of TMS are delivered on every trial. Each block of the study is randomized to receive either delta-beta patterned (triplets of TMS pulses at 20 Hertz every 3 Hertz), theta-gamma patterned (triplets of pulses at 50 Hertz every 5 Hertz), or an arrhythmic pattern (same number of pulses and duration with a random inter-pulse interval). After stimulation, a questionnaire is provided with common side effects of TMS. Based on the results of the stimulation side effects questionnaire, a structured adverse events interview is conducted to acquire more information regarding any side effects that were selected to be "very high" by the participant. The third and fourth session will each take approximately two hours.

Being tested
Delta-beta TMS, Theta-gamma TMS, Arrhythmic TMS

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delta-beta TMSDevice

    TMS will be delivered in a delta-beta pattern in which triplets of pulses delivered at 20 Hz (50 milliseconds between each pulse) are sent every 3 Hz (333 milliseconds between the start of each triplet).

  • Theta-gamma TMSDevice

    TMS will be delivered in a theta-gamma pattern in which triplets of pulses delivered at 50 Hz (20 milliseconds between each pulse) are sent every 5 Hz (200 milliseconds between the start of each triplet).

  • Arrhythmic TMSDevice

    TMS will be delivered in an arrhythmic pattern in which pulses are delivered with a random inter-pulse interval. The number of pulses and duration is matched to that of the Delta-beta TMS and Theta-gamma TMS.

Study groups in NCT05593965
Study groupRoleWhat they receive
TMS to lateral prefrontal cortex followed by TMS to medial prefrontal cortexExperimentalParticipants will receive TMS while performing a reward-based decision-making task. In the first stimulation session, the TMS coil will be placed over the lateral prefrontal cortex on the scalp. In the second session, the TMS coil will be placed over the medial prefrontal cortex on the scalp. during every session, subjects receive Delta-beta patterned TMS, Theta-gamma patterned TMS, and Arrhythmic TMS.
Receives: Device: Delta-beta TMS; Device: Theta-gamma TMS; Device: Arrhythmic TMS
TMS to medial prefrontal cortex followed by TMS to lateral prefrontal cortexExperimentalParticipants will receive TMS while performing a reward-based decision-making task. In the first stimulation session, the TMS coil will be placed over the medial prefrontal cortex on the scalp. In the second session, the TMS coil will be placed over the lateral prefrontal cortex on the scalp. during every session, subjects receive Delta-beta patterned TMS, Theta-gamma patterned TMS, and Arrhythmic TMS.
Receives: Device: Delta-beta TMS; Device: Theta-gamma TMS; Device: Arrhythmic TMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of the Trials That the Participant Chooses to Perform the Hard Task

    In the Expenditure of Effort for Reward Task, participants are faced with a decision on every trial: to choose an easy task with a low effort exertion for a chance at winning a low amount of money and a hard task with a high effort exertion for a chance at winning a greater amount of money. The incentive for the high effort exertion is changed on each trial and the participant gets physically tired from repeated effort exertion. Goal-directed behavior was calculated as the percentage of trials in which the participant decides to perform the most difficult effort exertion task in the Expenditure of Effort for Reward Task. A higher percentage equates to more goal-directed behavior and is favorable.

    Measured: 2 hours during the 1st intervention and 2 hours during the 2nd intervention

Secondary outcomes (1)
  1. Coupling Strength Between Low-frequency Prefrontal Signals and High-frequency Posterior Signals

    Phase-amplitude coupling strength is calculated using the mean vector length metric between low-frequency activity in prefrontal electrodes and high-frequency activity in motor electrodes. A Z-score indicates the number of standard deviations away from the mean of distribution generated by randomly time-shifting the data. A Z-score of 0 is equal to the mean coupling strength of random data. Higher values are greater coupling strength. Positive values (> 1) indicate increased prefrontal control over the motor cortex, which is found in healthy individuals during decision-making.

    Measured: 2 hours during the 1st intervention and 2 hours during the 2nd intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2022
  2. Study start10 Jan 2023
  3. Primary completion31 Jul 2023
  4. Study completion31 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05593965
Sponsor's protocol ID
22-2430
Other IDs
1K99MH126161-01A1
Acronym
NANCY
Status last verified
Sep 2023
First submitted
21 Oct 2022
Last updated
17 Jul 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board, Independent Ethics Committee, or Research Ethics Board, as applicable, and executes a data use/sharing agreement with the University of North Carolina at Chapel Hill.

Questions about this trial

What is this clinical trial studying?

A study testing Delta-beta TMS, Theta-gamma TMS and Arrhythmic TMS in people with Executive Function, run by University of North Carolina, Chapel Hill at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 Jul 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of the Trials That the Participant Chooses to Perform the Hard Task (time frame: 2 hours during the 1st intervention and 2 hours during the 2nd intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in